Cell and Gene Therapy Catapult, UCLB and Imperial Innovations Announce Positive Interim Review

News   Apr 13, 2016

 
Cell and Gene Therapy Catapult, UCLB and Imperial Innovations Announce Positive Interim Review
 
 
 

RELATED ARTICLES

Putting the Brain at the Center of Anesthesiology

News

Emery N. Brown explains how statistics and neuroscience improve anesthesiology at the American Association for the Advancement of Science's annual meeting.

READ MORE

Induced Pluripotent Stem Cells Could Serve as Cancer Vaccine

News

Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a study in mice suggests another use for iPS cells: training the immune system to attack or even prevent tumors.

READ MORE

Absolute Antibody and Kerafast Merge Increasing Access to Unique Reagents and Recombinant Antibody Technology

News

Absolute Antibody Ltd., and Kerafast Inc., have announced a merger of the two companies. The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE